|
Name |
12,13-dihydroxyfumitremorgin C
|
Molecular Formula | C22H25N3O5 | |
IUPAC Name* |
(1R,2S,12S,15S)-1,2-dihydroxy-7-methoxy-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione
|
|
SMILES |
CC(=C[C@H]1C2=C([C@@H]([C@@]3(N1C(=O)[C@@H]4CCCN4C3=O)O)O)C5=C(N2)C=C(C=C5)OC)C
|
|
InChI |
InChI=1S/C22H25N3O5/c1-11(2)9-16-18-17(13-7-6-12(30-3)10-14(13)23-18)19(26)22(29)21(28)24-8-4-5-15(24)20(27)25(16)22/h6-7,9-10,15-16,19,23,26,29H,4-5,8H2,1-3H3/t15-,16-,19-,22+/m0/s1
|
|
InChIKey |
CPHRCQUGNAGVIB-FWJAZRMLSA-N
|
|
Synonyms |
12,13-dihydroxyfumitremorgin C; 12alpha,13alpha-dihydroxyfumitremorgin C; 111427-99-7; (5aR,6S,12S,14aS)-5a,6-dihydroxy-9-methoxy-12-(2-methylprop-1-en-1-yl)-1,2,3,5a,6,11,12,14a-octahydro-5H,14H-pyrrolo[1'',2'':4',5']pyrazino[1',2':1,6]pyrido[3,4-b]indole-5,14-dione; (5aR,6S,12S,14aS)-5a,6-Dihydroxy-9-methoxy-12-(2-methylprop-1-en-1-yl)-1,2,3,5a,6,14a-hexahydropyrrolo[1'',2'':4',5']pyrazino[1',2':1,6]pyrido[3,4-b]indole-5,14(11H,12H)-dione; CHEMBL3884139; CHEBI:72764; DTXSID001305297; BS-1142; C20605; Q27140131; (1R,2S,12S,15S)-1,2-dihydroxy-7-methoxy-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione
|
|
CAS | 111427-99-7 | |
PubChem CID | 10001648 | |
ChEMBL ID | CHEMBL3884139 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 411.5 | ALogp: | 1.1 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 106.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 30 | QED Weighted: | 0.658 |
Caco-2 Permeability: | -5.051 | MDCK Permeability: | 0.00000638 |
Pgp-inhibitor: | 0.793 | Pgp-substrate: | 0.911 |
Human Intestinal Absorption (HIA): | 0.179 | 20% Bioavailability (F20%): | 0.025 |
30% Bioavailability (F30%): | 0.946 |
Blood-Brain-Barrier Penetration (BBB): | 0.469 | Plasma Protein Binding (PPB): | 81.81% |
Volume Distribution (VD): | 1.013 | Fu: | 12.02% |
CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.118 |
CYP2C19-inhibitor: | 0.336 | CYP2C19-substrate: | 0.83 |
CYP2C9-inhibitor: | 0.451 | CYP2C9-substrate: | 0.772 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.152 |
CYP3A4-inhibitor: | 0.469 | CYP3A4-substrate: | 0.93 |
Clearance (CL): | 6.251 | Half-life (T1/2): | 0.391 |
hERG Blockers: | 0.068 | Human Hepatotoxicity (H-HT): | 0.94 |
Drug-inuced Liver Injury (DILI): | 0.983 | AMES Toxicity: | 0.013 |
Rat Oral Acute Toxicity: | 0.903 | Maximum Recommended Daily Dose: | 0.983 |
Skin Sensitization: | 0.258 | Carcinogencity: | 0.418 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.984 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003264 | 1.000 | D06YFA | 0.278 | ||||
ENC003265 | 0.837 | D0J4JM | 0.270 | ||||
ENC002064 | 0.769 | D0G8NJ | 0.268 | ||||
ENC003013 | 0.732 | D01TSI | 0.256 | ||||
ENC000837 | 0.673 | D0P0RX | 0.256 | ||||
ENC001060 | 0.636 | D02IQY | 0.255 | ||||
ENC002274 | 0.636 | D0H4JM | 0.254 | ||||
ENC002846 | 0.629 | D00XHD | 0.250 | ||||
ENC005479 | 0.600 | D0SP3D | 0.249 | ||||
ENC002260 | 0.595 | D09NNH | 0.249 |